share_log

Scotiabank Initiates Coverage On Avidity Biosciences With Sector Outperform Rating, Announces Price Target of $70

Benzinga ·  Mar 7 22:22  · Ratings

Scotiabank analyst Louise Chen initiates coverage on Avidity Biosciences (NASDAQ:RNA) with a Sector Outperform rating and announces Price Target of $70.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 313

Recommended

Write a comment